Cleavage of anti-apoptotic Bcl-2 family members after TCR stimulation contributes to the decision between T cell activation and apoptosis

Journal of Immunology

Volumn 190, Issue 1, 2013, Pages 168-173

  Guerrero, Alan D ^a   Welschhans, Robert L ^a   Chen, Min ^a   Wang, Jin ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2; PROTEIN BCL XL; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN CROSS LINKING; T LYMPHOCYTE ACTIVATION; UPREGULATION; WESTERN BLOTTING; WILD TYPE;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; BCL-X PROTEIN; CELL DEATH; CELL LINE; CELL SURVIVAL; HUMANS; HYDROLYSIS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, INBRED MRL LPR; MULTIGENE FAMILY; PRIMARY CELL CULTURE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR CROSS-TALK; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTE SUBSETS;

EID: 84871849271     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201610     Document Type: Article

References (33)

1. Nagata, S., and T. Suda. 1995. Fas and Fas ligand: lpr and gld mutations. Immunol. Today 16: 39-43.
2. Lenardo, M., K. M. Chan, F. Hornung, H. McFarland, R. Siegel, J. Wang, and L. Zheng. 1999. Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment. Annu. Rev. Immunol. 17: 221-253. (Pubitemid 29241124)
3. Hughes, P., P. Bouillet, and A. Strasser. 2006. Role of Bim and other Bcl-2 family members in autoimmune and degenerative diseases. Curr. Dir. Autoimmun. 9: 74-94.
4. Mountz, J. D., J. Wu, J. Cheng, and T. Zhou. 1994. Autoimmune disease. A problem of defective apoptosis. Arthritis Rheum. 37: 1415-1420. (Pubitemid 24337682)
5. Strasser, A., P. J. Jost, and S. Nagata. 2009. The many roles of FAS receptor signaling in the immune system. Immunity 30: 180-192.
6. Krammer, P. H., R. Arnold, and I. N. Lavrik. 2007. Life and death in peripheral T cells. Nat. Rev. Immunol. 7: 532-542. (Pubitemid 46987784)
7. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356: 314-317.
8. Lynch, D. H., M. L. Watson, M. R. Alderson, P. R. Baum, R. E. Miller, T. Tough, M. Gibson, T. Davis-Smith, C. A. Smith, K. Hunter, et al. 1994. The mouse Fasligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1: 131-136.
9. Ramsdell, F., M. S. Seaman, R. E. Miller, T. W. Tough, M. R. Alderson, and D. H. Lynch. 1994. gld/gld mice are unable to express a functional ligand for Fas. Eur. J. Immunol. 24: 928-933. (Pubitemid 24093790)
10. Takahashi, T., M. Tanaka, C. I. Brannan, N. A. Jenkins, N. G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76: 969-976. (Pubitemid 24106378)
11. Nagata, S. 1997. Apoptosis by death factor. Cell 88: 355-365. (Pubitemid 27131377)
12. Krammer, P. H. 2000. CD95's deadly mission in the immune system. Nature 407: 789-795.
13. Hughes, P. D., G. T. Belz, K. A. Fortner, R. C. Budd, A. Strasser, and P. Bouillet. 2008. Apoptosis regulators Fas and Bim cooperate in shutdown of chronic immune responses and prevention of autoimmunity. Immunity 28: 197-205. (Pubitemid 351215234)
14. Hutcheson, J., J. C. Scatizzi, A. M. Siddiqui, G. K. Haines, III, T. Wu, Q. Z. Li, L. S. Davis, C. Mohan, and H. Perlman. 2008. Combined deficiency of proapoptotic regulators Bim and Fas results in the early onset of systemic autoimmunity. Immunity 28: 206-217. (Pubitemid 351215233)
15. Weant, A. E., R. D. Michalek, I. U. Khan, B. C. Holbrook, M. C. Willingham, and J. M. Grayson. 2008. Apoptosis regulators Bim and Fas function concurrently to control autoimmunity and CD8+ T cell contraction. Immunity 28: 218- 230.
16. Snow, A. L., J. B. Oliveira, L. Zheng, J. K. Dale, T. A. Fleisher, and M. J. Lenardo. 2008. Critical role for BIM in T cell receptor restimulationinduced death. Biol. Direct 3: 34.
17. Oliveira, J. B., N. Bidère, J. E. Niemela, L. Zheng, K. Sakai, C. P. Nix, R. L. Danner, J. Barb, P. J. Munson, J. M. Puck, et al. 2007. NRAS mutation causes a human autoimmune lymphoproliferative syndrome. Proc. Natl. Acad. Sci. USA 104: 8953-8958. (Pubitemid 47175418)
18. Kim, H., M. Rafiuddin-Shah, H. C. Tu, J. R. Jeffers, G. P. Zambetti, J. J. Hsieh, and E. H. Cheng. 2006. Hierarchical regulation of mitochondrion- dependent apoptosis by BCL-2 subfamilies. Nat. Cell Biol. 8: 1348-1358. (Pubitemid 44835109)
19. Willis, S. N., J. I. Fletcher, T. Kaufmann, M. F. van Delft, L. Chen, P. E. Czabotar, H. Ierino, E. F. Lee, W. D. Fairlie, P. Bouillet, et al. 2007. Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science 315: 856-859.
20. Cheng, E. H., D. G. Kirsch, R. J. Clem, R. Ravi, M. B. Kastan, A. Bedi, K. Ueno, and J. M. Hardwick. 1997. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 278: 1966-1968. (Pubitemid 28013242)
21. Clem, R. J., E. H. Cheng, C. L. Karp, D. G. Kirsch, K. Ueno, A. Takahashi, M. B. Kastan, D. E. Griffin, W. C. Earnshaw, M. A. Veliuona, and J. M. Hardwick. 1998. Modulation of cell death by Bcl-XL through caspase interaction. Proc. Natl. Acad. Sci. USA 95: 554-559.
22. Chen, M., A. D. Guerrero, L. Huang, Z. Shabier, M. Pan, T. H. Tan, and J. Wang. 2007. Caspase-9-induced mitochondrial disruption through cleavage of antiapoptotic BCL-2 family members. J. Biol. Chem. 282: 33888-33895. (Pubitemid 350159562)
23. Hakem, R., A. Hakem, G. S. Duncan, J. T. Henderson, M. Woo, M. S. Soengas, A. Elia, J. L. de la Pompa, D. Kagi, W. Khoo, et al. 1998. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 94: 339-352. (Pubitemid 28376078)
24. Cepero, E., A. M. King, L. M. Coffey, R. G. Perez, and L. H. Boise. 2005. Caspase-9 and effector caspases have sequential and distinct effects on mitochondria. Oncogene 24: 6354-6366. (Pubitemid 41486469)
25. Lakhani, S. A., A. Masud, K. Kuida, G. A. Porter, Jr., C. J. Booth, W. Z. Mehal, I. Inayat, and R. A. Flavell. 2006. Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science 311: 847-851. (Pubitemid 43228848)
26. Samraj, A. K., E. Keil, N. Ueffing, K. Schulze-Osthoff, and I. Schmitz. 2006. Loss of caspase-9 provides genetic evidence for the type I/II concept of CD95- mediated apoptosis. J. Biol. Chem. 281: 29652-29659. (Pubitemid 44536973)
27. Samraj, A. K., D. Sohn, K. Schulze-Osthoff, and I. Schmitz. 2007. Loss of caspase-9 reveals its essential role for caspase-2 activation and mitochondrial membrane depolarization. Mol. Biol. Cell 18: 84-93. (Pubitemid 46066713)
28. Guerrero, A. D., M. Chen, and J. Wang. 2008. Delineation of the caspase-9 signaling cascade. Apoptosis 13: 177-186.
29. Chen, M., K. Felix, and J.Wang. 2012. Critical role for perforin and Fas-dependent killing of dendritic cells in the control of inflammation. Blood 119: 127-136.
30. Chen, M., Y. H. Wang, Y. Wang, L. Huang, H. Sandoval, Y. J. Liu, and J. Wang. 2006. Dendritic cell apoptosis in the maintenance of immune tolerance. Science 311: 1160-1164.
31. Schroers, R., and S. Y. Chen. 2004. Lentiviral transduction of human dendritic cells. Methods Mol. Biol. 246: 451-459.
32. Lenardo, M. J. 1991. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 353: 858-861. (Pubitemid 21912642)
33. Zheng, L., C. L. Trageser, D. M. Willerford, and M. J. Lenardo. 1998. T cell growth cytokines cause the superinduction of molecules mediating antigen-induced T lymphocyte death. J. Immunol. 160: 763-769. (Pubitemid 28049317)